PR Needed NEW Request / Tyroid Molecular Tests - THYROSEQ 5 year contract

Summary (Newest Update)

Background The contract is issued by the VA Puget Sound Health Care System (VAPSHCS) in Seattle, which aims to enhance the assessment of indeterminate thyroid nodules through molecular testing. This testing is crucial for detecting genetic alterations associated with thyroid malignancy and helps stratify patients regarding the necessity of surgical procedures. Work Details The contractor will provide molecular testing services for thyroid nodule fine needle aspiration (FNA) specimens. The testing will be conducted at an outside laboratory, where FNA specimens are placed into transport media supplied by the contractor and shipped using their shipping materials. The estimated volume of tests to be performed annually at VAPSHCS is approximately 120 molecular tests per year based on current biopsy rates and the rate of indeterminate nodules. Period of Performance 5 years Place of Performance Seattle VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108 Bidder Requirements The contractor must provide transport media and shipping materials for the FNA specimens. Incumbent Analysis (see Incumbents section for more detail) This opportunity appears to have a confirmed incumbent, as Cytopath Biopsy Lab holds contract 36C26024P0181 (award value $316,000; 01/01/24–12/31/28) for thyroid molecular testing at VA Puget Sound Health Care System. The prior work and the current requirement both involve performing THYROSEQ molecular testing on thyroid nodule FNA specimens from indeterminate nodules, including specimen packaging/transport to an outside laboratory and returning results to support surgical decision-making. Additional closely related awards under Cytopath Biopsy Lab (e.g., THYROSEQ lab tests for malignancy determination and clinical molecular THYROSEQ services) further indicate continuity of the same testing workflow and purpose.